Home
Resources
Publications
Adrenocortical Carcinoma

Adrenocortical Carcinoma

Eric Baudin, Endocrine Tumor Board of Gustave Roussy

Endocrinol Metab Clin North Am. 2015 Jun;44(2):411-34.

PMID: 26038209

Abstract:

Recent developments in the treatment of adrenocortical carcinoma (ACC) include diagnostic and prognostic risk stratification algorithms, increasing evidence of the impact of historical therapies on overall survival, and emerging targets from integrated epigenomic and genomic analyses. Advances include proper clinical and molecular characterization of all patients with ACC, standardization of proliferative index analyses, referral of these patients to large cancer referral centers at the time of first surgery, and development of new trials in patients with well-characterized ACC. Networking and progress in the molecular characterization of ACC constitute the basis for significant future therapeutic breakthroughs.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP53190-B	Mitotane		53-19-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: